G6PD and cancer: Multiple GSEA analysis of G6PD showed that mTOR signaling, Notch signaling, and cancer pathways were mainly enriched in the high expression group, whereas other metabolic pathways, such as drug metabolism, fatty acid metabolism, and tryptophan metabolism were enriched in the low expression group (Figures 7E,F).